Skip to main content

Arcapta Side Effects

Generic name: indacaterol

Medically reviewed by Last updated on Feb 4, 2024.

Note: This document contains side effect information about indacaterol. Some dosage forms listed on this page may not apply to the brand name Arcapta.

Applies to indacaterol: inhalation capsule.

Serious side effects of Arcapta

Along with its needed effects, indacaterol (the active ingredient contained in Arcapta) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking indacaterol:

More common

Less common

Incidence not known

Other side effects of Arcapta

Some side effects of indacaterol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

For Healthcare Professionals

Applies to indacaterol: inhalation capsule.


The most commonly reported adverse reactions at the recommended doses were nasopharyngitis, cough, upper respiratory tract infection, headache, sinusitis, peripheral edema, and noncardiac chest pain (less than 1%). The majority of these side effects was mild to moderate and became less frequent if treatment was discontinued.

The most common serious adverse reactions reported were COPD exacerbation, pneumonia, angina pectoris, and atrial fibrillation.[Ref]


Very common (10% or more): Cough following inhalation (up to 24%), nasopharyngitis (up to 14.3%), upper respiratory tract infection (up to 14.2%)

Common (1% to 10%): Cough, sinusitis, rhinorrhea, chest pain

Uncommon (0.1% to 1%): Paradoxical bronchospasm, chest discomfort[Ref]


Common (1% to 10%): Oropharyngeal pain, throat irritation, nausea, dry mouth[Ref]


Common (1% to 10%): Diabetes mellitus, hyperglycemia[Ref]


Common (1% to 10%): Muscle spasm musculoskeletal pain

Uncommon (0.1% to 1%): Myalgia[Ref]

Nervous system

Common (1% to 10%): Headache

Uncommon (0.1% to 1%): Paresthesia, vertigo

Postmarketing reports: Dizziness[Ref]


Common (1% to 10%): Peripheral edema[Ref]


Uncommon (0.1% to 1%): Ischemic heart disease, atrial fibrillation, palpitations, tachycardia

Postmarketing reports: Tachycardia, heart rate increase, palpitations[Ref]


Uncommon (0.1% to 1%): Pruritus, rash[Ref]


Postmarketing reports: Hypersensitivity reactions[Ref]


1. Cerner Multum, Inc. UK Summary of Product Characteristics.

2. Cerner Multum, Inc. Australian Product Information.

3. Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals. 2011.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.